Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 37 of Cartesian Therapeutics, Inc.'s SEC filings and found 3 warrant series, 3 convertibles, 2 ATM programs, 4 shelf registrations, 1 S-1 registration and 1 completed offering on file for RNAC. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 2, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
PYXSPyxis Oncology, Inc.
DTILPrecision BioSciences, Inc.
AKBAAkebia Therapeutics, Inc.
ADCTADC Therapeutics SA
CGENCompugen Ltd
INOInovio Pharmaceuticals, Inc.
ACIUAC Immune SA
PRQRProQR Therapeutics N.V. Ordinary Shares
PLXProtalix BioTherapeutics, Inc.
ARTVArtiva Biotherapeutics, Inc.
PALIPalisade Bio, Inc.
IKTInhibikase Therapeutics, Inc.
BBOTBridgeBio Oncology Therapeutics Inc.
ACOGAlpha Cognition Inc
NAGENiagen Bioscience Inc